1. Home
  2. OGEN vs YHC Comparison

OGEN vs YHC Comparison

Compare OGEN & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.16

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo LQR House Inc.

YHC

LQR House Inc.

SELL

Current Price

$1.73

Market Cap

2.2M

ML Signal

SELL

Company Overview

Basic Information
Metric
OGEN
YHC
Founded
1996
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.2M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
OGEN
YHC
Price
$0.16
$1.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 246.6K
83.0K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,120,622.00
Revenue This Year
N/A
$1,254.00
Revenue Next Year
N/A
$21.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 86.42
52 Week Low
$0.13
$1.21
52 Week High
$1.11
$4,480.00

Technical Indicators

Market Signals
Indicator
OGEN
YHC
Relative Strength Index (RSI) 14.14 43.62
Support Level N/A $1.61
Resistance Level $0.59 $2.09
Average True Range (ATR) 0.03 0.26
MACD -0.02 -0.02
Stochastic Oscillator 10.60 25.32

Price Performance

Historical Comparison
OGEN
YHC

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

Share on Social Networks: